APP and Alzheimer disease: While experimental models have shown potential synergistic or overlapping molecular mechanisms generating AD and LBD pathology [54–57], it is also apparent that LBD is commonly present in subjects where AD pathology is clearly primary, such as in autosomal dominant mutations of PS1 and APP [57–62], or even in other cerebral amyloidoses [63].